Month: April 2020

HALIFAX, Nova Scotia, April 23, 2020 (GLOBE NEWSWIRE) — Morien Resources Corp. (“Morien” or the “Company”) (TSXV:MOX) today announces that its Annual and Special Meeting of Shareholders will be held in a virtual-only format, and that its 2020 Notice of Annual and Special Meeting, Management Information Circular and Form of Proxy are now available on SEDAR.Virtual Annual and Special Meeting of ShareholdersMorien’s Virtual Annual and Special Meeting of Shareholders (the “Meeting”) will be held on Wednesday, May 20 at 1:00 p.m. ET (2:00 p.m. AT).  Due to the public health impact of COVID-19 the Company will hold the Meeting in a virtual-only format, with proceedings conducted solely via live audio by phone and webcast.  Shareholders who elect to attend the Meeting may do so by calling 877-407-2991 (toll-free)...

NEODESHA, Kan., April 23, 2020 (GLOBE NEWSWIRE) — AgEagle Aerial Systems, Inc. (NYSE American: UAVS), an industry leading provider of advanced drone imagery-based data collection and analytics solutions, will hold a conference call on Thursday, April 30, 2020 at 11:00 a.m. Eastern time to provide a corporate update and discuss recent operational highlights.AgEagle CEO Barrett Mooney and CFO Nicole Fernandez-McGovern will host the conference call. Investors and analysts are encouraged to submit questions they would like management to address during the discussion via email to UAVS@gatewayir.com by Wednesday, April 29, 2020 at 5:00 p.m. Eastern time.Conference Call Date: Thursday, April 30, 2020Time: 11:00 a.m. Eastern time (10:00 a.m. Central time)Toll-free dial-in number: 888-437-3179International dial-in number: 862-298-0701Please...

Westport, CT, April 23, 2020 (GLOBE NEWSWIRE) —Merimepodib is shown to decrease viral production of COVID-19 coronavirus more than remdesivir at clinically meaningful drug concentrations in pre-clinical testing.Article highlights recent work done in laboratory studies of COVID-19 with merimepodib at the Galveston National Laboratory at The University of Texas Medical BranchBioSig Technologies, Inc. (Nasdaq: BSGM) today announced that an article titled, “The IMPDH inhibitor merimepodib has similar antiviral activity against SARS-CoV-2 replication in vitro to the adenosine analogue remdesivir” was accepted by F1000 Research, an  online peer-reviewed life sciences journal publishing program in biology and medicine.This manuscript is authored by Natalya Bukreyeva, Rachel A. Sattler, Emily K. Mantlo, John T. Manning, Cheng Huang and...

Orphazyme A/SCompany announcement                                                                                       No. 32/2020                                                                                                          Company Registration No. 32266355Copenhagen, Denmark, April 23, 2020 – Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces that a share capital increase has been registered with the Danish Business Authority as a result of the exercise of Restricted Share Units by board members. A total of 1,927 shares of nominally DKK 1 each have been issued by the Company.Reference is made to company announcement no. 31/2020 of April 22, 2020.Following the share capital increase, the total nominal share capital...

ROBIT PLC               STOCK EXCHANGE RELEASE            23 APRIL 2020 AT 16.10CORRECTION: ROBIT PLC INTERIM REPORT 1 JANUARY-31 MARCH 2020: NET SALES AND ORDER INTAKE GREWRobit corrects and completes the information in the net sales tables in the Finnish version of the interim report.A change percentage has been added to the table for both business unit and market area data.In addition, in the market area table, the full year 2019 net sales for Europe, the Middle East and Africa market area has been corrected.Incorrect information: Europe, the Middle East and Africa market area, net sales full year 2019: 17,432 thousand eurosCorrected information: Europe, the Middle East and Africa market area, net sales full year 2019: EUR 36,190 thousand eurosIn the English interim report, the tables were presented correctly.The corrected report in...

ROBIT OYJ                 PÖRSSITIEDOTE                  23.4.2020 KLO 16.10KORJAUS: ROBIT OYJ OSAVUOSIKATSAUS 1.1.-31.3.2020: LIIKEVAIHTO JA SAADUT TILAUKSET KASVOIVATRobit korjaa ja täydentää suomenkielisen osavuosikatsauksen liikevaihtotaulukoissa olevia tietoja.Taulukkoon on lisätty muutosprosentti sekä liiketoimintayksikökohtaiseen että markkina-aluekohtaiseen tietoon. Lisäksi markkina-aluekohtaisen taulukon Eurooppa, Lähi-itä ja Afrikka -markkina-alueen liikevaihto koko vuoden 2019 osalta on korjattu.Virheellinen tieto: Eurooppa, Lähi-itä ja Afrikka -alueen liikevaihto 2019: 17 432 tuhatta euroaKorjattu tieto: Eurooppa, Lähi-itä ja Afrikka -alueen liikevaihto 2019: 36 190 tuhatta euroaEnglanninkielisessä osavuosikatsauksessa taulukot on esitetty oikein.Alla korjattu tiedote kokonaisuudessaan sekä liitteenä korjattu osavuosikatsaus...

CATSKILL, N.Y., April 23, 2020 (GLOBE NEWSWIRE) — Greene County Bancorp, Inc. (NASDAQ-GCBC) today announced that its Board of Directors has approved a quarterly cash dividend of $0.11 per share on the Company’s common stock. The dividend reflects an annual cash dividend rate of $0.44 per share, which is the same rate as the dividend declared during the previous quarter.The cash dividend for the quarter ended March 31, 2020 will be paid to shareholders of record as of May 15, 2020, and is expected to be paid on May 29, 2020.The Company is the majority-owned subsidiary of Greene County Bancorp, MHC (the “MHC”), a federal mutual holding company which owns 54.0% of the Company’s outstanding common shares.  The MHC is waiving its receipt of this dividend.  The MHC received the approval of its members (depositors of The Bank of Greene...